These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 549547

  • 1. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
    Carmina E, Lanzara P, Lo Coco R, Longo RA, Jannì A.
    Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547
    [Abstract] [Full Text] [Related]

  • 2. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Iacona T, Conte G, Fabrizi ML, Valle D, Anile C, Maira G.
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [Abstract] [Full Text] [Related]

  • 3. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM, Atkinson AB, Hadden DR, Kennedy L, Leslie H, Merrett JD, Sheridan B.
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [Abstract] [Full Text] [Related]

  • 4. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
    Nilsson A.
    Acta Endocrinol Suppl (Copenh); 1978 Jun; 216():217-24. PubMed ID: 274038
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K, Sasaki A, Sato S, Goh M, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [Abstract] [Full Text] [Related]

  • 6. Bromocriptine and glucose tolerance in acromegalics.
    Dolecek R, Kubis M, Sajnar J, Závada M.
    Pharmatherapeutica; 1982 Feb; 3(2):100-6. PubMed ID: 7048336
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF, van Liessum PA, Smals AG, van Gennep JA, Benraad TJ, Kloppenborg PW.
    Acta Endocrinol Suppl (Copenh); 1987 Feb; 286():9-18. PubMed ID: 2892339
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone response to L-dopa in the thinned obese.
    Laurian L, Oberman Z, Hoerer E, Wiznitzer T, Harell A.
    Isr J Med Sci; 1982 May; 18(5):625-9. PubMed ID: 7096047
    [Abstract] [Full Text] [Related]

  • 9. [The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
    Kanatsuka A, Makino H, Matsushima Y, Osegawa M, Yamamoto M, Kumagai A.
    Nihon Naibunpi Gakkai Zasshi; 1978 May 20; 54(5):636-47. PubMed ID: 99332
    [Abstract] [Full Text] [Related]

  • 10. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S, Hall K, Sjöberg HE.
    Acta Endocrinol Suppl (Copenh); 1978 May 20; 216():199-206. PubMed ID: 347862
    [Abstract] [Full Text] [Related]

  • 11. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
    Dolecek R.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1056-7. PubMed ID: 989744
    [No Abstract] [Full Text] [Related]

  • 12. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M, Molteni N, Cantalamessa L, Bardella MT, Peracchi G, Orsatti A, Faggioli P, Bianchi PA.
    Am J Gastroenterol; 1992 May 27; 87(5):580-3. PubMed ID: 1595643
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
    Fossati P, Asfour M, Brion-Brevan B, Fourlinnie JC, Cappoen JP, Dalle-Furnari MA, Blacker C.
    Ann Endocrinol (Paris); 1977 May 27; 38(4):291-301. PubMed ID: 332054
    [Abstract] [Full Text] [Related]

  • 14. Reappraisal of bromocriptine treatment for acromegaly.
    Maneschi F.
    Horm Res; 1980 May 27; 12(4):191-205. PubMed ID: 7390405
    [Abstract] [Full Text] [Related]

  • 15. Sleep-related growth hormone release following 2-bromo-alpha-ergocriptine treatment in acromegalic patients.
    Chihara K, Kato Y, Abe H, Furumoto M, Maeda K.
    J Clin Endocrinol Metab; 1977 Jan 27; 44(1):78-84. PubMed ID: 576232
    [Abstract] [Full Text] [Related]

  • 16. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L, Ljunghall S, Wide L, Boström H.
    Acta Endocrinol Suppl (Copenh); 1978 Jan 27; 216():207-16. PubMed ID: 347863
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ, Donald RA, Espiner EA.
    Clin Endocrinol (Oxf); 1976 Mar 27; 5(2):167-74. PubMed ID: 1269163
    [Abstract] [Full Text] [Related]

  • 18. Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients.
    Fedele D, Molinari M, Meneghel A, Valerio A, Muggeo M, Tiengo A.
    J Endocrinol Invest; 1980 Mar 27; 3(2):149-53. PubMed ID: 6993548
    [Abstract] [Full Text] [Related]

  • 19. Transient appearance of a provocative growth hormone response to L-dopa following incomplete adenomectomy in an acromegalic patient.
    Takahara J, Yakushiji W, Yamuchi J, Miyoshi M, Hosogi H.
    J Clin Endocrinol Metab; 1977 Mar 27; 44(3):599-602. PubMed ID: 838854
    [Abstract] [Full Text] [Related]

  • 20. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
    Giustina A, Doga M, Bussi AR, Licini M, Schettino M.
    Acta Endocrinol (Copenh); 1993 Feb 27; 128(2):131-5. PubMed ID: 7680832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.